Marina Basina MD
Diabetes, Lipid Metabolism, Thyroid
Clin Prof, Medicine - Endocrinology, Gerontology, & Metabolism, Stanford University Medical Center
Join to view full profile
300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000
Dr. Basina is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Marina Basina, based in Stanford, CA, specializes in endocrinology with subspecialties in diabetes, lipid metabolism, and thyroid disease. She completed her residency in Internal Medicine at UCLA-VA Greater Los Angeles and a fellowship in Endocrinology, Diabetes, and Metabolism at Stanford University. Dr. Basina is experienced in managing metabolic syndrome, diabetes mellitus, obesity, and thyroid disorders. Her recent publications focus on diabetes management, including anxiety, reproductive health, and peer mentoring in diabetes care. She has conducted clinical trials, including a principal investigator role in a study on Sotagliflozin for diabetic kidney disease. Her recognitions include multiple CMS Meaningful Use Certifications and the Fellows Teaching Award from Stanford University's Department of Medicine.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 2001 - 2003
UCLA-VA Greater Los AngelesResidency, Internal Medicine, 1998 - 2001
Moscow State University of Medicine and DentistryClass of 1987
Certifications & Licensure
CA State Medical License 2000 - 2028
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2017
- Fellows Teaching Award Stanford University Department of Medicine, 2012
Clinical Trials
- Rosiglitazone-Induced Weight Gain
- Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease Start of enrollment: 2024 Oct 31
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Intrathyroidal parathyroid carcinoma in a patient with multiple endocrine neoplasia type 1.Arita Thatte, Marina Basina, Kaniksha Desai
JCEM Case Reports. 2026-09-01 - 1 citationsHyperglycemia During Acute Pancreatitis and Progression to Early-Onset Diabetes After Recovery: Preliminary Findings From the Diabetes Related to Acute Pancreatitis an...Kathleen M Dungan, Vernon M Chinchilli, Ariana Pichardo-Lowden, Nazia Raja-Khan, Melena D Bellin
Diabetes Care. 2026-06-01 - Poor Glycemic Status Is Associated With Diabetes Distress After Total Pancreatectomy With Islet Autotransplantation.Faidat Adeola Ishola, Anne Eaton, Seung Kim, Marina Basina, Gregory Beilman
Clinical Transplantation. 2026-05-01
Press Mentions
Compounded GLP-1s: Why Doctors Worry and the FDA Is Cracking DownJuly 16th, 2026- Weekly Insulin Shots for Type 2 Diabetes May Be as Effective as Daily ShotsSeptember 11th, 2024
- Statin Use Associated with Type 2 Diabetes ProgressionOctober 9th, 2021
Grant Support
- The Stanford Clinical Center for the Study of Type 1 Diabetes in Acute PancreatitisSTANFORD UNIVERSITY2020–2030
- Rosiglitazone-Induced Weight GAINNational Center For Research Resources2006–2008
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
